TrialThe Lancet. Global health2021

Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.

Stephen Kimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.